Jane Street Group, LLC Intercept Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$72.9 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.99 - $18.71 $469,719 - $879,725	-47,019 Reduced 76.8%	14,201 $263,000
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $236,778 - $498,087	-25,821 Reduced 29.67%	61,220 $677,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $1.09 Million - $1.89 Million	87,041 New	87,041 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $3.55 Million - $5.72 Million	290,537 New	290,537 $4.05 Million
Q2 2022 Aug 16, 2022	SELL	$11.23 - $19.59 $533,043 - $929,858	-47,466 Closed	0 $0

Q1 2022 May 17, 2022	SELL	$13.37 - $17.79 $1.45 Million - $1.92 Million	-108,129 Reduced 69.49%	47,466 $773,000
Q4 2021 Feb 15, 2022	BUY	$14.28 - $19.53 $892,342 - $1.22 Million	62,489 Added 67.12%	155,595 $2.54 Million
Q3 2021 Nov 16, 2021	BUY	$12.99 - $20.47 $458,936 - $723,205	35,330 Added 61.15%	93,106 $1.38 Million
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $229,426 - $363,580	14,840 Added 34.56%	57,776 $1.15 Million
Q1 2021 May 18, 2021	BUY	$19.33 - $37.75 $148,203 - $289,429	7,667 Added 21.74%	42,936 $991,000
Q4 2020 Feb 17, 2021	SELL	$24.48 - $42.47 $286,220 - $496,559	-11,692 Reduced 24.9%	35,269 $871,000
Q3 2020 Nov 17, 2020	BUY	$39.09 - $53.44 $277,187 - $378,943	7,091 Added 17.79%	46,961 $1.95 Million
Q2 2020 Aug 17, 2020	BUY	$46.7 - $92.04 $1.01 Million - $1.99 Million	21,625 Added 118.53%	39,870 $1.91 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $660,412 - $1.62 Million	13,659 Added 297.84%	18,245 $1.15 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $450,964 - $975,674	-7,862 Reduced 63.16%	4,586 $568,000
Q3 2019 Nov 14, 2019	SELL	$58.69 - $80.46 $1.07 Million - $1.47 Million	-18,232 Reduced 59.43%	12,448 $826,000
Q1 2019 May 16, 2019	BUY	$91.83 - $120.68 $628,025 - $825,330	6,839 Added 28.69%	30,680 $3.43 Million
Q4 2018 Feb 15, 2019	SELL	$85.79 - $126.46 $112,384 - $165,662	-1,310 Reduced 5.21%	23,841 $2.4 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $1.01 Million - $1.46 Million	11,421 Added 83.18%	25,151 $3.18 Million
Q2 2018 Aug 15, 2018	SELL	$60.0 - $85.67 $521,940 - $745,243	-8,699 Reduced 38.78%	13,730 $1.15 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $29,997 - $38,265	569 Added 2.6%	22,429 $1.38 Million
Q4 2017 Feb 15, 2018	SELL	$58.2 - $72.76 $566,635 - $708,391	-9,736 Reduced 30.81%	21,860 $1.28 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $1.8 Million - $3.75 Million	31,596	31,596 $1.83 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account